Evaluating the benefit of immunotherapy for Stage III melanoma. Desai AD, Ibrahim SJ, Samie FH. J Am Acad Dermatol 2024 Apr 27:S0190-9622(24)00679.

Read + Share

Amedeo Smart

Independent Medical Education

Desai AD, Ibrahim SJ, Samie FH. Evaluating the benefit of immunotherapy for Stage III melanoma. J Am Acad Dermatol 2024 Apr 27:S0190-9622(24)00679.
PMID: 38685406